Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by an agonist of peroxisome proliferator-activated receptor-γ

Journal of Neuroimmunology

Volumn 116, Issue 1, 2001, Pages 40-48

  Niino, Masaaki ^a,b   Iwabuchi, Kazuya ^b   Kikuchi, Seiji ^a   Ato, Manabu ^b   Morohashi, Taiki ^b   Ogata, Akihiko ^a   Tashiro, Kunio ^a   Onoé, Kazunori ^b  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Experimental autoimmune encephalomyelitis; Multiple sclerosis; Myelin oligodendrocyte glycoprotein; PPAR ; Troglitazone

Indexed keywords

CYTOKINE; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TROGLITAZONE;

ADIPOCYTE; ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; FEMALE; INFLAMMATION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT OUTCOME;

ANIMALS; CELL DIVISION; CHROMANS; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; INFLAMMATION MEDIATORS; MICE; MICE, INBRED C57BL; MYELIN-ASSOCIATED GLYCOPROTEIN; PEPTIDE FRAGMENTS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REFERENCE VALUES; RNA, MESSENGER; T-LYMPHOCYTES; THIAZOLES; THIAZOLIDINEDIONES; TRANSCRIPTION FACTORS;

EID: 0035341427     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(01)00285-5     Document Type: Article

References (33)

1. Differential cytokine expression in acute and chronic murine graft-versus-host-disease
2. Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins
3. Surface expression of α4 integrin by CD4 T cells is required for their entry into brain parenchyma
4. Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-α, -β, and -γ in the adult rat
5. Cytokine localization in multiple sclerosis lesions: Correlation with adhesion molecule expression and reactive nitrogen species
6. Peroxisome proliferator-activated receptor (PPAR) γ: Adipose-predominant expression and induction early in adipocyte differentiation
7. Activation of proliferator-activated receptors α and γ induces apoptosis of human monocyte-derived macrophages
8. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction
9. The nuclear receptor PPAR γ and immunoregulation: PPAR γ mediates inhibition of helper T cell responses
10. Isolation of the human peroxisome proliferator activated receptor γ cDNA: Expression in hematopoietic cells and chromosomal mapping
11. A novel antidiabetic drug, troglitazone - Reason for hope and concern
12. Induction of CTL responses by simultaneous administration of liposomal peptide vaccine with anti-CD40 and anti-CTLA-4 mAb
13. 2 production in response to lipopolysaccharide in the macrophage cell line J774A.1
14. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
15. 2 induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats
16. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors
17. Unimpaired autoreactive T-cell traffic within the central nervous system during tumor necrosis factor receptor-mediated inhibition of experimental autoimmune encephalomyelitis
18. The nuclear receptor superfamily: The second decade
19. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis
20. Protective effect of the interleukin-1 receptor antagonist (IL-1ra) on experimental allergic encephalomyelitis in rats
21. In vivo cytokine gene expression in T cell subsets of the autoimmune MRL/Mp-lpr/lpr mouse
22. Amelioration of experimental autoimmune uveoretinitis by pretreatment with a pathogenic peptide in liposome and anti-CD40 ligand monoclonal antibody
23. 2
24. Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1
25. The peroxisome proliferator-activated receptor γ is a negative regulator of macrophage activation
26. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis
27. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro
28. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination
29. cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor
30. A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response
31. mPPAR γ 2: Tissue-specific regulator of an adipocyte enhancer
32. Stimulation of adipogenesis in fibroblasts by PPAR γ 2, a lipid-activated transcription factor
33. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells